Actively Recruiting
Activation of Biobank for Association Study Between Environmental and Genetic Factors in Inflammatory, Functional and Neoplastic Bilio-pancreatic Diseases
Led by IRCCS San Raffaele · Updated on 2025-05-02
2000
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the role of genetic predisposition and environmental factors in multifactorial bilio-pancreatic diseases, including inflammatory, functional, and neoplastic conditions such as pancreatitis and pancreatic adenocarcinoma. The study aims to better understand how these combined factors contribute to disease development for improved prevention and early diagnosis. This observational study is sponsored by IRCCS San Raffaele and collects both retrospective and prospective biological samples and clinical data. Participants provide various biological samples depending on their condition, including peripheral and portal blood, saliva, urine, stool, cystic fluid, pancreatic juice, and biopsy tissues. The biobank collects and stores these samples to facilitate analysis of genetic and environmental influences on bilio-pancreatic diseases. There is no treatment or intervention administered, as this is an observational study. During the study, researchers collect and analyze clinical data and biological samples to measure the rate of patients with pancreatic disorders who show specific exposures or biomarkers. The study lasts about one year on average, with ongoing monitoring through study completion. Participants' involvement includes providing consent and samples, with no additional treatment or procedures required.
CONDITIONS
Brief Title
Activation of Biobank Registry for Bilio-pancreatic Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Signed informed consent
You will not qualify if you...
- Younger than 18 years
- Unwilling to sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year
Participants provide various biological samples depending on their disease, including blood, saliva, urine, stool, cystic fluid, pancreatic juice, and biopsy tissue specimens.
Visits as needed for sample collection over the study period
Duration - Up to study completion (approximately 3 years)
Participants are observed for disease progression and exposure to certain biomarkers over the course of the study.
Follow-up visits depending on participant status and disease progression
Trial Site Locations
Total: 1 location
1
IRCCS OSpedale San Raffaele
Milan, Italy, 20132
Actively Recruiting
Research Team
G
Gabriele Capurso, MD
L
Laura Apadula, MSN
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here